What Is the Next in Developing Model to Predict Survival Outcomes of Resected Pancreatic Cancer? = What Is the Next in Developing Model to Predict Survival Outcomes of Resected Pancreatic Cancer?

참고문헌 (Reference)

1 Xing H, "Preoperative prediction of pathological grade in pancreatic ductal adenocarcinoma based on 18F-FDG PET/CT radiomics" 11 : 19-, 2021

2 The Korean Association of HBP Surgery, "Korea Tumor Registration Database-BP" The Korean Association of HBP Surgery

3 Chang N, "Development and multicenter validation of a CT-based radiomics signature for discriminating histological grades of pancreatic ductal adenocarcinoma" 10 : 692-702, 2020

4 Kang Jae Seung, "Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP)" 거트앤리버 소화기연관학회협의회 15 (15): 912-921, 2021

5 Li K, "Contrast-enhanced CT radiomics for predicting lymph node metastasis in pancreatic ductal adenocarcinoma : a pilot study" 20 : 12-, 2020

6 Bergquist JR, "Carbohydrate antigen 19-9 elevation in anatomically resectable, early stage pancreatic cancer is independently associated with decreased overall survival and an indication for neoadjuvant therapy : a national cancer database study" 223 : 52-65, 2016

7 National Cancer Institute Surveillance, Epidemiology and End Results Program, "About the SEER program" National Cancer Institute

8 Liang X, "A radiomics model that predicts lymph node status in pancreatic cancer to guide clinical decision making : a retrospective study" 12 : 6050-6057, 2021

9 Nasief H, "A machine learning based delta-radiomics process for early prediction of treatment response of pancreatic cancer" 3 : 25-, 2019

10 Kaissis G, "A machine learning algorithm predicts molecular subtypes in pancreatic ductal adenocarcinoma with differential response to gemcitabine-based versus FOLFIRINOX chemotherapy" 14 : e0218642-, 2019